D-index as a Predictor of Complication of Treatment of Patients With Acute Myeloid Leukemia
ConditionAML, Adult
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorAssiut University
About this trial
1. The effect of D-index on the onset and severity of FN in AML patients. 2. Relationship between the c-D-index and duration of FN in AML patients. 3. Correlation between D-index and MDR. 4. Correlation between D-index and invasive fungal infection. 5. Comparison of FN in different treatment protocols for AML using D-index. 6. Prediction of pulmonary, fungal or blood stream infection.
Eligibility criteria
Qualifiers
Adult Patients (≥18 years) newly diagnosed as acute myeloid leukemia according to WHO 2016 diagnostic criteria.
Hematologic diagnosis of de novo AML.
Eastern Cooperative Oncology Group performance status (ECOG PS) 0-2.
Standard induction chemotherapy (7+3 regimen) or consolidation regimens (HiDAC).
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov